Drug repositioning of antipsychotic drugs for cisplatin-induced pica behavior in mice

We aimed to clarify whether various antipsychotics ameliorate cisplatin-induced pica behavior in mice using a drug repositioning approach. Mice were administered cisplatin (12.5 mg/kg, i.p.) with or without olanzapine (1 mg/kg, i.p.), asenapine (4 mg/kg, i.p.), mirtazapine (5 mg/kg, i.p.) or standard three-drug antiemetics (granisetron [0.5 mg/kg, i.p.], fosaprepitant [25 mg/kg, i.p.], and dexamethasone [3 mg/kg, i.p.]). Kaolin, food, and water intake, and spontaneous motor activity on the day before and seven consecutive days after the cisplatin administration were measured using a telemetry system. At the primary endpoint, kaolin intake was significantly higher at day three in the cisplatin group than in the pre-treatment and saline groups ( p < 0.05). Additionally, kaolin intake was not significantly higher in cisplatin with olanzapine, asenapine, and mirtazapine groups for seven days than in the pre-treatment group. At the secondary endpoint, cisplatin decreased the food and water intake, and spontaneous motor activity in a time-dependent manner. Three antipsychotics failed to improve the cisplatin-induced decrease in food and water intake, and spontaneous motor activity. The findings suggest that prophylactic administration of antipsychotics besides olanzapine may improve cisplatin-induced nausea and vomiting in a delayed phase and de-escalate standard 3-drug antiemetics.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:76

Enthalten in:

Die Pharmazie - 76(2021), 10 vom: 01. Okt., Seite 484-487

Sprache:

Englisch

Beteiligte Personen:

Sekiguchi, M [VerfasserIn]
Sagano, N [VerfasserIn]
Kawazoe, H [VerfasserIn]
Hiraga, Y [VerfasserIn]
Jibiki, A [VerfasserIn]
Yokoyama, Y [VerfasserIn]
Suzuki, S [VerfasserIn]
Nakamura, T [VerfasserIn]

Links:

Volltext

Themen:

7S5I7G3JQL
Antineoplastic Agents
Antipsychotic Agents
Cisplatin
Dexamethasone
Journal Article
Q20Q21Q62J
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 18.03.2022

Date Revised 18.03.2022

published: Print

Citation Status MEDLINE

doi:

10.1691/ph.2021.1674

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM33161281X